RxDoctor Payments Data

Monica Howard, MD

Family Medicine · Germantown, MDNPI 1720130255

Payments from drug & device makers

$658in general payments, 2019–2025

Across 38 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$183
  • AbbVie$86
  • Takeda Pharmaceuticals U.S.A., Inc.$81
  • AstraZeneca$78
  • Abbott$56
  • Sanofi Pasteur Inc.$35
  • plus $138 from 7 others

What the payments were for

  • Food & beverage$658100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$658 in reported general payments places this provider in the 60th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$361,513
Medicare patients
1,108
Services billed
4,937

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$83,916
EliquisApixaban40$52,982
FarxigaDapagliflozin Propanediol33$51,645
MounjaroTirzepatide43$49,104
JanuviaSitagliptin Phosphate23$28,240
JardianceEmpagliflozin21$28,131
MyrbetriqMirabegron24$16,628
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$7,948
SynthroidLevothyroxine Sodium82$5,966
Rosuvastatin Calcium228$5,763
Diclofenac Sodium17$4,525
Atorvastatin Calcium256$3,764
Metoprolol Succinate153$3,653
Amlodipine Besylate341$3,021
Olmesartan Medoxomil78$2,705

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$183$83,91645 claims
PfizerEliquis$28$52,98240 claims
AstraZenecaFarxiga$78$51,64533 claims
MerckJanuvia$31$28,24023 claims
Astellas Pharma US IncMyrbetriq$16$16,62824 claims
AbbVieSynthroid$86$5,96682 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Germantown

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →